Benign Prostatic Hyperplasia (BPH), or enlarged prostate, is a common condition affecting millions of men, especially those over 50. It can lead to uncomfortable urinary symptoms and significantly ...
SAN JOSE, Calif., Aug. 21, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing ...
Procept Biorobotics is a top performer in the medical device industry, offering relief for men with BPH. The company's minimally invasive procedure is experiencing rapid growth in both system sales ...
PROCEPT BioRobotics announced positive WATER III trial results for Aquablation therapy in large prostates, showing effective outcomes and reduced complications. PROCEPT BioRobotics Corporation ...
SAN JOSE, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through ...
The pros and cons of aquablation and HoLEP differ for benign prostate hyperplasia treatment. (HealthDay News) — For men with benign prostate hyperplasia, aquablation provides temporary benefits for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results